Efficacy and safety of traditional Chinese medicine treatment for idiopathic pulmonary fibrosis: An exploratory, randomized, double-blinded and placebo controlled trial
Background and objective: Idiopathic pulmonary fibrosis (IPF) is a critical disease, with limited treatments available. Clinical practices show that traditional Chinese medicine (TCM) has certain efficacy. This study was preliminarily to evaluate the efficacy and safety of TCM treatment based on syn...
Main Authors: | Jiansheng Li, Xue-qing Yu, Yang Xie, Shu-guang Yang, Limin Zhao, Miao Zhou, Yong Meng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1053356/full |
Similar Items
-
Efficacy and safety of Jin-shui Huan-xian granule for idiopathic pulmonary fibrosis: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
by: Shu-guang Yang, et al.
Published: (2022-09-01) -
Efficacy and safety of traditional Chinese medicine in patients with acute exacerbation of idiopathic pulmonary fibrosis: study protocol for randomized, controlled, exploratory clinical trial
by: Zhang Hailong, et al.
Published: (2022-02-01) -
Analysis of the safety and efficacy of different plasma concentrations of pirfenidone in patients with idiopathic pulmonary fibrosis
by: Hui Li, et al.
Published: (2022-11-01) -
Integrated bioinformatics analysis for the identification of idiopathic pulmonary fibrosis–related genes and potential therapeutic drugs
by: Zhenzhen Zhang, et al.
Published: (2023-10-01) -
A prognostic model of idiopathic pulmonary fibrosis constructed based on macrophage and mitochondria-related genes
by: Yu Bao, et al.
Published: (2024-04-01)